Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats

European Respiratory Journal

Volumn 40, Issue 6, 2012, Pages 1420-1429

  De La Roque, Eric Dumas ^a,b,c   Bellance, Nadège ^b   Rossignol, Rodrigue ^b   Begueret, Hugues ^a,b,c   Billaud, Marie ^a,b   Dos Santos, Pierre ^b,c   Ducret, Thomas ^a,b   Marthan, Roger ^a,b,c   Dahan, Diana ^a,b   Ramos Barboń, David ^d   Amor Carro, Óscar ^d   Savineau, Jean Pierre ^a,b,c   Fayon, Michael ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cardiac myocyte; Chronic hypoxia; Dehydroepiandrosterone; Mitochondria; Pulmonary hypertension

Indexed keywords

PRASTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; ELECTRON MICROSCOPY; HEART MUSCLE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; ISOLATED HEART; MALE; MICROSCOPY; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; REOXYGENATION; RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION; RIGHT VENTRICULAR SYSTOLIC DYSFUNCTION;

ANIMALS; ANOXIA; APOPTOSIS; CREB-BINDING PROTEIN; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; MALE; MICROSCOPY; MICROSCOPY, ELECTRON; MITOCHONDRIA; MYOCYTES, CARDIAC; OXYGEN; PERFUSION; RATS; RATS, WISTAR; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84871238599     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00011511     Document Type: Article

References (40)

1. Marthan R, Castaing Y, Manier G, et al. Gas exchange alterations in patients with chronic obstructive lung disease. Chest 1985; 87: 470-475. (Pubitemid 15083485)
2. Bogaard HJ, Abe K, Vonk Noordegraaf A, et al. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009; 135: 794-804.
3. Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32: 1371-1385.
4. Weitzenblum E, Chaouat A, Canuet M, et al. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Semin Respir Crit Care Med 2009; 30: 458-470.
5. Naeije R, Dewachter L. Animal models of pulmonary arterial hypertension. Rev Mal Respir 2007; 24: 481-496. (Pubitemid 46697453)
6. Stenmark KR, Meyrick B, Galie N, et al. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 2009; 297: L1013-L1032.
7. Bonnet S, Dumas-de-La-Roque E, Begueret H, et al. Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension. Proc Natl Acad Sci USA 2003; 100: 9488-9493. (Pubitemid 37033955)
8. Bonnet S, Dubuis E, Vandier C, et al. Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing. Cardiovasc Res 2002; 53: 1019-1028. (Pubitemid 34261040)
9. Bonnet P, Bonnet S, Boissiere J, et al. Chronic hypoxia induces nonreversible right ventricle dysfunction and dysplasia in rats. Am J Physiol Heart Circ Physiol 2004; 287: H1023-H1028. (Pubitemid 39096646)
10. Barbera JA, Roca J, Ferrer A, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 1285-1291. (Pubitemid 27278247)
11. Moore RP, Berlowitz DJ, Denehy L, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax 2011; 66: 32-37.
12. Hampl V, Bibova J, Povysilova V, et al. Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats. Eur Respir J 2003; 21: 862-865. (Pubitemid 36592298)
13. Dumas de la Roque E, Savineau JP, Bonnet S. Dehydroepiandrosterone: a new treatment for vascular remodeling diseases including pulmonary arterial hypertension. Pharmacol Ther 2010; 126: 186-199.
14. Dumas de La Roque E, Savineau JP, Metivier AC, et al. Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study. Ann Endocrinol (Paris) 2012; 73: 20-25.
15. Alwardt CM, Yu Q, Brooks HL, et al. Comparative effects of dehydroepiandrosterone sulfate on ventricular diastolic function with young and aged female mice. Am J Physiol Regul Integr Comp Physiol 2006; 290: R251-R256.
16. Iwasaki T, Mukasa K, Yoneda M, et al. Marked attenuation of production of collagen type I from cardiac fibroblasts by dehydroepiandrosterone. Am J Physiol Endocrinol Metab 2005; 288: E1222-E1228. (Pubitemid 40726810)
17. Jacob MH, Janner Dda R, Bello-Klein A, et al. Dehydroepiandrosterone modulates antioxidant enzymes and Akt signaling in healthy Wistar rat hearts. J Steroid Biochem Mol Biol 2008; 112: 138-144.
18. National Institutes of Health. Guide for the Care and Use of Laboratory Animals, 85-23. Bethesda, NIH Publications, 1996.
19. European Union. Council directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations, and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official J Eur Union 1986; L358: 1-28.
20. Yang DL, Zhang HG, Xu YL, et al. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats. Clin Exp Pharmacol Physiol 2010; 37: 150-155.
21. Colomer JM, Terasawa M, Means AR. Targeted expression of calmodulin increases ventricular cardiomyocyte proliferation and deoxyribonucleic acid synthesis during mouse development. Endocrinology 2004; 145: 1356-1366. (Pubitemid 38281020)
22. Billaud M, Marthan R, Savineau JP, et al. Vascular smooth muscle modulates endothelial control of vasoreactivity via reactive oxygen species production through myoendothelial communications. PLoS One 2009; 4: e6432.
23. Benard G, Faustin B, Passerieux E, et al. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol 2006; 291: C1172-C1182. (Pubitemid 44878587)
24. Ramos-Barbon D, Presley JF, Hamid QA, et al. Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma. J Clin Invest 2005; 115: 1580-1589. (Pubitemid 40814666)
25. Fraga-Iriso R, Nunez-Naveira L, Brienza NS, et al. Development of a murine model of airway inflammation and remodeling in experimental asthma. Arch Bronconeumol 2009; 45: 422-428.
26. Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310: 314-317. (Pubitemid 41457197)
27. Vankoningsloo S, De Pauw A, Houbion A, et al. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes. J Cell Sci 2006; 119: 1266-1282.
28. Wallace DC. Animal models for mitochondrial disease. Methods Mol Biol 2002; 197: 3-54.
29. Benard G, Rossignol R. Ultrastructure of the mitochondrion and its bearing on function and bioenergetics. Antioxid Redox Signal 2008; 10: 1313-1342.
30. Makino A, Suarez J, Gawlowski T, et al. Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes. Am J Physiol Regul Integr Comp Physiol 2011; 300: R1296-1302.
31. Camara AK, Bienengraeber M, Stowe DF. Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury. Front Physiol 2011; 2: 13.
32. Bhuiyan MS, Fukunaga K. Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo. Eur J Pharmacol 2007; 557: 168-177. (Pubitemid 46186288)
33. Patel MA, Katyare SS. Treatment with dehydroepiandrosterone (DHEA) stimulates oxidative energy metabolism in the liver mitochondria from developing rats. Mol Cell Biochem 2006; 293: 193-201. (Pubitemid 44843014)
34. Patel MA, Katyare SS. Dehydroepiandrosterone (DHEA) treatment stimulates oxidative energy metabolism in the cerebral mitochondria from developing rats. Int J Dev Neurosci 2006; 24: 327-334. (Pubitemid 43975698)
35. Lehman JJ, Barger PM, Kovacs A, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000; 106: 847-856.
36. Gerhart-Hines Z, Rodgers JT, Bare O, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J 2007; 26: 1913-1923. (Pubitemid 46624046)
37. Grasfeder LL, Gaillard S, Hammes SR, et al. Fasting-induced hepatic production of DHEA is regulated by PGC-1α, ERRα, and HNF4α. Mol Endocrinol 2009; 23: 1171-1182.
38. Tsutsui H, Kinugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 2009; 81: 449-456.
39. Rohrdanz E, Schmuck G, Ohler S, et al. Changes in antioxidant enzyme expression in response to hydrogen peroxide in rat astroglial cells. Arch Toxicol 2001; 75: 150-158. (Pubitemid 32449045)
40. Dyner TS, Lang W, Geaga J, et al. An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J Acquir Immune Defic Syndr 1993; 6: 459-465. (Pubitemid 23139916)